Localized adenovirus gene delivery using antiviral IgG complexation

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Gene Therapy

• Publication date

  2001-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.gt.3301452PMID 11406760
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• FGF2-Targeted adenovirus encoding platelet-derived growth factor-B enhances de novo tissue formation.

  2000cited by this paper
• Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues.

  1999cited by this paper
• Cancer gene therapy with HSV‐tk/GCV system depends on t‐cell‐mediated immune responses and causes apoptotic death of tumor cells In vivo

  1999cited by this paper
• Cancer gene therapy with HSV-tk/GCV system depends on T-cell-mediated immune responses and causes apoptotic death of tumor cells in vivo.

  1999cited by this paper
• Bystander effect of purine nucleoside analogues in HSV-1tk suicide gene therapy is superior to that of pyrimidine nucleoside analogues

  1999cited by this paper
• A versatile method for the conjugation of proteins and peptides to poly[2-(dimethylamino)ethyl methacrylate].

  1999cited by this paper
• DNA delivery from polymer matrices for tissue engineering

  1999cited by this paper
• Coacervate microspheres as carriers of recombinant adenoviruses

  1999cited by this paper
• In Situ Gene Therapy for Adenocarcinoma of the Prostate: A Phase I Clinical Trial

  1999cited by this paper
• Long-acting gonadotropin-releasing hormone implant to maintain medical castration for two years in men with prostate cancer.

  1999cited by this paper
• Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration

  1999cited by this paper
• Adenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: results of a phase 1 clinical trial

  1999cited by this paper
• A Phase I/II Study of Hepatic Artery Infusion with wtp53-CMV-Ad in Metastatic Malignant Liver Tumours

  1999cited by this paper
• Gene transfection using biodegradable nanospheres: results in tissue culture and a rat osteotomy model

  1999cited by this paper
• Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy

  1999cited by this paper
• Sustained delivery of proteins for novel therapeutic agents.

  1998cited by this paper
• Poly (lactic-glycolic) acid copolymer encapsulation of recombinant adenovirus reduces immunogenicity in vivo

  1998cited by this paper
• A DNA controlled-release coating for gene transfer: transfection in skeletal and cardiac muscle.

  1998cited by this paper
• Human gene therapy for hereditary diseases: a review of trials.

  1998cited by this paper
• Gene therapy for malignant pleural mesothelioma.

  1998cited by this paper
• Reversible hydrogels from self-assembling artificial proteins.

  1998cited by this paper
• Drug delivery and targeting.

  1998cited by this paper
• Developing adenoviral-mediated in vivo gene therapy for ornithine transcarbamylase deficiency

  1998cited by this paper
• Antisense oligonucleotide inhibition of PDGFR-beta receptor subunit expression directs suppression of intimal thickening.

  1997cited by this paper
• Adenovirus infection in cystic fibrosis patients: Implications for the use of adenoviral vectors for gene transfer

  1996cited by this paper
• Gene therapy for lung cancer: enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus-mediated p53 gene transfer.

  1996cited by this paper
• Adenovirus-Mediated Transfer of the Herpes Simplex Virus Thymidine Kinase Gene Inhibits Vascular Smooth Muscle Cell Proliferation and Neointima Formation Following Balloon Angioplasty of the Rat Carotid Artery

  1995cited by this paper
• Effects of antisense c-myb oligonucleotides on vascular smooth muscle cell proliferation and response to vessel wall injury.

  1995cited by this paper
• Uses of fusions of beta-galactosidase and peptides to proteins.

  1994cited by this paper
• Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model.

  1994cited by this paper
• In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.

  1994cited by this paper
• Enzymatic cleavage of disaccharide side groups in insoluble synthetic polymers: a new method for specific delivery of drugs to the colon.

  1993cited by this paper
• Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ deposition.

  1993cited by this paper
• Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo

  1992cited by this paper
• New methods of drug delivery.

  1990cited by this paper
• Polymers for the sustained release of proteins and other macromolecules

  1976cited by this paper

• Multifunctional DNA-Collagen Biomaterials: Developmental Advances and Biomedical Applications

  2025cites this paper
• Contact-Triggered Lipofection from Multilayer Films Designed as Surfaces for In Situ Transfection Strategies in Tissue Engineering.

  2020cites this paper
• Is Viral Vector Gene Delivery More Effective Using Biomaterials?

  2020cites this paper
• Surface- and Hydrogel-Mediated Delivery of Nucleic Acid Nanoparticles.

  2019cites this paper
• Controlled Release Systems for DNA Delivery Controlled Release Systems for DNA Delivery

  2019cites this paper
• Discovery: The Student Journal of Dale Bumpers College of Agricultural, Food and Life Sciences-Volume 7 2006

  2018cites this paper
• Implementation of a stratified approach and gene immobilization to enhance the osseointegration of a silk-based ligament graft.

  2017cites this paper
• Controlled Gene Delivery Systems for Articular Cartilage Repair

  2017cites this paper
• Hydrogel-Based Controlled Delivery Systems for Articular Cartilage Repair

  2016cites this paper
• Polymer-Anchored Adenovirus as a Therapeutic Agent for Cancer Gene Therapy

  2016cites this paper
• The use of polymer-based nanoparticles and nanostructured materials in treatment and diagnosis of cardiovascular diseases: Recent advances and emerging designs

  2016cites this paper
• Controlled release strategies for modulating immune responses to promote tissue regeneration.

  2015cites this paper
• Live Imaging of Cellular Internalization of Single Colloidal Particle by Combined Label-Free and Fluorescence Total Internal Reflection Microscopy.

  2015cites this paper
• Immobilization of FLAG-Tagged Recombinant Adeno-Associated Virus 2 onto Tissue Engineering Scaffolds for the Improvement of Transgene Delivery in Cell Transplants

  2015cites this paper
• MicroRNA delivery for regenerative medicine.

  2015cites this paper
• Vascular gene transfer from metallic stent surfaces using adenoviral vectors tethered through hydrolysable cross-linkers.

  2014cites this paper
• Immobilized Lentivirus Vector on Chondroitin Sulfate-Hyaluronate Acid-Silk Fibroin Hybrid Scaffold for Tissue-Engineered Ligament-Bone Junction

  2014cites this paper
• Local sustained delivery of oncolytic adenovirus with injectable alginate gel for cancer virotherapy

  2013cites this paper
• A PLG/HAp composite scaffold for lentivirus delivery.

  2013cites this paper
• Surface- and hydrogel-mediated delivery of nucleic acid nanoparticles.

  2013cites this paper
• Pseudotyped adeno-associated viral vectors for gene transfer in dermal fibroblasts: implications for wound-healing applications.

  2013cites this paper
• ZEIN: NOVEL NATURAL POLYMER FOR NANOPARTICLE- AND FILM- MEDIATED GENE DELIVERY

  2013cites this paper
• Engineering Biomaterials for Regenerative Medicine: Novel Technologies for Clinical Applications

  2012cites this paper
• PHYSIOCHEMICAL STABILITY AND MASS SPECTROMETRIC ANALYSIS OF GEMINI SURFACTANT-BASED LIPOPLEXES

  2012cites this paper
• Nonviral Gene Delivery for Applications in Regenerative Medicine

  2012cites this paper
• Engineering biomaterial systems to enhance viral vector gene delivery.

  2011cites this paper
• Engineering fibrinogen-binding VSV-G envelope for spatially- and cell-controlled lentivirus delivery through fibrin hydrogels.

  2011cites this paper
• Substrate-mediated nucleic acid delivery from self-assembled monolayers.

  2011cites this paper
• Controlling Nonviral Gene Delivery through the Cell-Biomaterial Interface

  2010cites this paper
• Phosphatidylserine immobilization of lentivirus for localized gene transfer.

  2010cites this paper
• Localized cell uptake of His-tagged polyplexes immobilized on NTA self-assembled monolayers.

  2010cites this paper
• Lentivirus immobilization to nanoparticles for enhanced and localized delivery from hydrogels.

  2010cites this paper
• Mechanism of sustained release of vascular endothelial growth factor in accelerating experimental diabetic healing.

  2009cites this paper
• Lentivirus delivery by adsorption to tissue engineering scaffolds.

  2009cites this paper
• Spatial control of gene delivery on bioengineered scaffolds for tissue regeneration

  2009cites this paper
• The use of reactive polymer coatings to facilitate gene delivery from poly (epsilon-caprolactone) scaffolds.

  2009cites this paper
• Hydrogel compositions for nonviral gene delivery

  2009cites this paper
• Enhancement of Mesenchymal Stem Cell Attachment to Decellularized Porcine Aortic Valve Scaffold by In Vitro Coating with Antibody Against CD90: A Preliminary Study on Antibody-Modified Tissue-Engineered Heart Valve

  2008cites this paper
• Characterization and real-time imaging of gene expression of adenovirus embedded silk-elastinlike protein polymer hydrogels.

  2008cites this paper
• Immobilization of plasmid DNA on an anti‐DNA antibody modified coronary stent for intravascular site‐specific gene therapy

  2008cites this paper
• Polymers for viral gene delivery

  2008cites this paper
• Development of adenovirus immobilization strategies for in situ gene therapy

  2008cites this paper
• Matrices and scaffolds for DNA delivery in tissue engineering.

  2007cites this paper
• The status of gene vectors for the treatment of diabetes

  2007cites this paper
• Preparation and identification of monoclonal antibodies against the adenovirus vector

  2007cites this paper
• Initial evaluation of novel preparations of Bordetella avium by determination of antibody response titers

  2006cites this paper
• Immobilization of gene vectors on polyurethane surfaces using a monoclonal antibody for localized gene delivery

  2006cites this paper
• Gene Technology in Tissue Engineering

  2006cites this paper
• Site specific gene delivery in the cardiovascular system.

  2005cites this paper
• Gene delivery through cell culture substrate adsorbed DNA complexes.

  2005cites this paper
• Immobilization of gene vector on polyurethane surface using monoclonal antibody for site-specific gene therapy

  2005cites this paper
• Substrate-mediated delivery from self-assembled monolayers: effect of surface ionization, hydrophilicity, and patterning.

  2005cites this paper
• DNA delivery from hyaluronic acid-collagen hydrogels via a substrate-mediated approach.

  2005cites this paper
• Gene Delivery by Immobilization to Cell-Adhesive Substrates

  2005cites this paper
• Crosslinked hyaluronic acid hydrogels: a strategy to functionalize and pattern.

  2005cites this paper
• Localized gene delivery using antibody tethered adenovirus from polyurethane heart valve cusps and intra-aortic implants

  2004cites this paper
• Controlled release systems for DNA delivery.

  2004cites this paper
• Delivery systems for small molecule drugs, proteins, and DNA: the neuroscience/biomaterial interface.

  2004cites this paper
• Gene delivery from polymer scaffolds for tissue engineering

  2004cites this paper
• Substrate-mediated DNA delivery: role of the cationic polymer structure and extent of modification.

  2003cites this paper
• Gene therapy progress and prospects: adenoviral vectors

  2003cites this paper
• The Incorporation of an Ion Channel Gene Mutation Associated with the Long QT Syndrome (Q9E-hMiRP1) in a Plasmid Vector for Site-Specific Arrhythmia Gene Therapy: In Vitro and In Vivo Feasibility Studies

  2003cites this paper
• DNA delivery from an intravascular stent with a denatured collagen-polylactic-polyglycolic acid-controlled release coating: mechanisms of enhanced transfection

  2003cites this paper
• Gene therapy in transplantation.

  2002cites this paper
• Gene Delivery to Pig Coronary Arteries from Stents Carrying Antibody-Tethered Adenovirus

  2002cites this paper
• International Journal of Nanomedicine Dovepress Local Gene Delivery via Endovascular Stents Coated with Dodecylated Chitosan–plasmid Dna Nanoparticles

  year unknowncites this paper